Browsing Tag
Tonix Pharmaceuticals
8 posts
Tonix Pharmaceuticals stock watch: Is this 28% jump the start of a biotech rebound or a speculative spike?
Tonix Pharmaceuticals stock soared 28% on May 27. Is it a biotech comeback or just a short squeeze? Read the deep dive on TNXP’s pipeline, sentiment, and funding risks.
Tonix, NuScale, and Pony AI lead U.S. gainers on May 27: AI, biotech, and energy stocks drive speculative rally
Tonix, NuScale, and Pony AI led U.S. gainers on May 27. See what triggered rallies across AI, biotech, and clean energy as institutions rotated back in.
Wall Street hit by broad-based sell-off as renewable, healthcare, and tech stocks tumble
Renewable energy, healthcare, and tech stocks led losses in the U.S. stock market on May 22, 2025. Explore what triggered the sell-off and what’s next.
Tonix Pharmaceuticals stock up over 20%: Can TNX-102 SL and TNX-1700 fuel a turnaround in 2025?
Tonix Pharmaceuticals surged 21% despite deep losses, as retail traders bet on TNX-102 SL’s FDA nod and cancer pipeline momentum. Read the full story.
Why Reddit, US Steel, and biotech stocks exploded as Trump’s tariffs shocked global markets
Find out which US stocks soared on April 7 as tariffs, AI growth, and biotech breakthroughs drove sharp gains across steel, tech, and energy sectors.
FDA acceptance propels Tonix Pharmaceuticals’ TNX-102 SL towards fibromyalgia treatment approval
Tonix Pharmaceuticals Holding Corp. has achieved a pivotal milestone with the FDA acceptance announcement for its New Drug…
Shocking Mpox surge: Over 15,000 cases in Africa—WHO sounds alarm
Africa is facing a significant health crisis as the mpox outbreak has surged, prompting the World Health Organization…
Tonix Pharmaceuticals gets FDA clearance for TNX-1900 phase 2 trial in chronic migraineurs
Tonix Pharmaceuticals is set to launch a phase 2 clinical trial of TNX-1900 (intranasal potentiated oxytocin) in migraine…